Breaking News Instant updates and real-time market news.

FTSV

Forty Seven

$14.48

-0.57 (-3.79%)

08:25
01/22/19
01/22
08:25
01/22/19
08:25

Forty Seven to hold KOL breakfast symposium

Key Opinion Leader Breakfast Symposium to discuss the company's initial development strategy for FSI-174 will be held in New York on January 22 at 8:30 am. Webcast Link

  • 22

    Jan

FTSV Forty Seven
$14.48

-0.57 (-3.79%)

12/21/18
BTIG
12/21/18
INITIATION
Target $36
BTIG
Buy
Forty Seven initiated with a Buy at BTIG
BTIG analyst Robert Hazlett started Forty Seven with a Buy rating and $36 price target. The company develops therapeutics based on the "transformational discovery" of CD47 as a novel immune pathway that controls signals that cells send to macrophages, Hazlett tells investors in a research note. The analyst believes blocking CD47 signaling has the potential to enable and enhance anti-cancer macrophage activity, as well as incremental adaptive immune responses, leading to potential broad anti-cancer activity for anti-CD47 approaches.
11/30/18
11/30/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Casa Systems (CASA) initiated with a Buy at Needham. 2. Charles Schwab (SCHW) and E-Trade (ETFC) were initiated with a Buy at Goldman Sachs. 3. Forty Seven (FTSV) initiated with a Buy at H.C. Wainwright. 4. Akoustis (AKTS) initiated with a Buy at Lake Street. 5. Everi Holdings (EVRI) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/30/18
HCWC
11/30/18
INITIATION
Target $21
HCWC
Buy
Forty Seven initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Forty Seven with a Buy rating and $21 price target. The company's lead product, 5F9, is an anti-CD47 antibody that triggers macrophages to eat cancer cells by blocking the CD47-SIRPalpha pathway, which is frequently exploited by cancer cells for immune evasion, Ramakanth tells investors in a research note. He believes data suggest that 5F9 is synergistic with existing immunotherapies by making the tumor microenvironment less tumorigenic. If successful, 5F9 could become an important next-generation CPI to enter the cancer immunotherapy market, which is expected to grow to $43B by 2022, says the analyst.
10/09/18
FBCO
10/09/18
NO CHANGE
FBCO
Outperform
Forty Seven selloff on Celgene trial ending seems premature, says Credit Suisse
After Celgene (CELG) disclosed the termination of its trial for CC-90002, an IgG4 construct that targets CD47, in acute myeloid leukemia and myelodysplastic syndrome patients, Credit Suisse analyst Martin Auster said the associated selloff in shares of Forty Seven (FTSV) seems premature to him. He does not believe the discontinuation in AML/MDS has a negative read-through to Forty Seven's 5F9 profile to date or its development in other indications, Auster tells investors. The analyst, who keeps an Outperform rating on Forty Seven shares, still sees promising efficacy in NHL providing a strong valuation base with substantial upside potential offered as 5F9 efficacy data matures.

TODAY'S FREE FLY STORIES

LPL

LG Display

$8.59

-0.895 (-9.44%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
LG Display falls -9.2% »

LG Display is down -9.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APH

Amphenol

$94.96

-10.44 (-9.91%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
Amphenol falls -9.7% »

Amphenol is down -9.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 22

    May

RES

RPC, Inc.

$11.43

-1.47 (-11.40%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
RPC, Inc. falls -12.0% »

RPC, Inc. is down -12.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 08

    May

  • 09

    May

  • 13

    Nov

SAP

SAP

$126.94

12.1 (10.54%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
SAP rises 10.5% »

SAP is up 10.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

TRK

Speedway Motorsports

$18.00

4.02 (28.76%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
Speedway Motorsports rises 28.8% »

Speedway Motorsports is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

APC

Anadarko

$71.57

7.45 (11.62%)

09:47
04/24/19
04/24
09:47
04/24/19
09:47
Hot Stocks
Anadarko rises 11.8% »

Anadarko is up 11.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 22

    May

IFRX

InflaRx

$51.42

(0.00%)

09:43
04/24/19
04/24
09:43
04/24/19
09:43
Recommendations
InflaRx analyst commentary at BMO Capital »

InflaRx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$62.35

(0.00%)

, SNAP

Snap

$11.99

(0.00%)

09:40
04/24/19
04/24
09:40
04/24/19
09:40
Options
Unusually active option classes on open April 24th »

Unusual total active…

OXY

Occidental Petroleum

$62.35

(0.00%)

SNAP

Snap

$11.99

(0.00%)

APC

Anadarko

$64.12

(0.00%)

T

AT&T

$32.11

(0.00%)

TXN

Texas Instruments

$116.37

(0.00%)

EBAY

eBay

$36.66

(0.00%)

SIRI

Sirius XM

$6.14

(0.00%)

CAT

Caterpillar

$142.08

(0.00%)

BX

Blackstone

$39.72

(0.00%)

TWTR

Twitter

$39.76

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 06

    May

  • 07

    May

  • 07

    May

  • 10

    May

  • 14

    May

  • 18

    May

  • 20

    May

  • 20

    May

  • 22

    May

  • 23

    May

  • 29

    May

  • 11

    Jun

  • 12

    Jun

09:40
04/24/19
04/24
09:40
04/24/19
09:40
General news
Treasury 5-year auction outlook: the $41 B continues to richen »

Treasury 5-year auction…

HAS

Hasbro

$100.34

12.32 (14.00%)

09:39
04/24/19
04/24
09:39
04/24/19
09:39
Recommendations
Hasbro analyst commentary at SunTrust »

Hasbro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

AMKR

Amkor Technology

$9.03

0.13 (1.46%)

09:38
04/24/19
04/24
09:38
04/24/19
09:38
Hot Stocks
Amkor Technology early strength attributed to speculation of Apple win »

An analyst is supposedly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 15

    May

T

AT&T

$32.11

0.03 (0.09%)

09:36
04/24/19
04/24
09:36
04/24/19
09:36
Hot Stocks
AT&T says cash flows 'continue to be impressive' »

Says: Confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

  • 06

    May

  • 07

    May

  • 18

    May

  • 20

    May

TV

Televisa

$10.54

-0.02 (-0.19%)

09:36
04/24/19
04/24
09:36
04/24/19
09:36
Downgrade
Televisa rating change at New Street »

Televisa downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 02

    May

  • 06

    May

RTRX

Retrophin

$19.71

-0.2 (-1.00%)

09:35
04/24/19
04/24
09:35
04/24/19
09:35
Conference/Events
Retrophin management to meet with SVB Leerink »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 04

    May

  • 07

    May

  • 08

    May

  • 05

    Jun

  • 30

    Jun

SHW

Sherwin-Williams

$460.43

8.6 (1.90%)

09:35
04/24/19
04/24
09:35
04/24/19
09:35
Recommendations
Sherwin-Williams analyst commentary at BMO Capital »

Sherwin-Williams price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGO

Argo Group

$73.94

0.53 (0.72%)

09:35
04/24/19
04/24
09:35
04/24/19
09:35
Hot Stocks
Voce Capital addresses Argo's 'attempted justifications for misuse of assets' »

Voce Capital Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

PAVM

PAVmed

$1.24

0.05 (4.20%)

09:35
04/24/19
04/24
09:35
04/24/19
09:35
Hot Stocks
PAVmed reports DisappEAR animal study results »

PAVmed announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

VSAT

ViaSat

$88.62

0.14 (0.16%)

09:34
04/24/19
04/24
09:34
04/24/19
09:34
Hot Stocks
ViaSat announces strategic partnership agreement with China Satcom »

Viasat and China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$31.58

1.04 (3.41%)

09:31
04/24/19
04/24
09:31
04/24/19
09:31
Conference/Events
Insmed management to meet with SVB Leerink »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 16

    May

  • 23

    Jun

OXY

Occidental Petroleum

$62.35

-0.69 (-1.09%)

09:30
04/24/19
04/24
09:30
04/24/19
09:30
Downgrade
Occidental Petroleum rating change at KeyBanc »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 10

    May

  • 29

    May

CARA

Cara Therapeutics

$18.90

1.21 (6.84%)

09:29
04/24/19
04/24
09:29
04/24/19
09:29
Conference/Events
Cara Therapeutics management to meet with Cantor Fitzgerald »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

TXN

Texas Instruments

$116.37

1.43 (1.24%)

09:27
04/24/19
04/24
09:27
04/24/19
09:27
Recommendations
Texas Instruments analyst commentary at Loop Capital »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    May

INSW

International Seaways

, TNP

TEN, Ltd.

$3.36

-0.04 (-1.18%)

09:25
04/24/19
04/24
09:25
04/24/19
09:25
Recommendations
International Seaways, TEN, Ltd., Scorpio Tankers, Euronav NV, DHT Holdings, Ardmore Shipping analyst commentary at Stifel »

U.S. sanctions on Iran…

INSW

International Seaways

TNP

TEN, Ltd.

$3.36

-0.04 (-1.18%)

STNG

Scorpio Tankers

$24.97

0.96 (4.00%)

EURN

Euronav NV

$9.56

-0.155 (-1.60%)

DHT

DHT Holdings

$5.17

0.075 (1.47%)

ASC

Ardmore Shipping

$7.14

0.17 (2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

AAPL

Apple

$207.50

2.88 (1.41%)

09:22
04/24/19
04/24
09:22
04/24/19
09:22
Periodicals
Kuo says Apple may launch new AirPods as soon as this year, CNBC reports »

Two new versions of Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 03

    Jun

HRB

H&R Block

$26.32

-0.385 (-1.44%)

09:19
04/24/19
04/24
09:19
04/24/19
09:19
Hot Stocks
H&R Block reports preliminary 2019 tax returns up 1.5% to 20.2M »

H&R Block released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.